Skip to content
10-K

Annual Report

TOURMALINE BIO, INC.

0001827506-25-000027

← back to feed
Filed
Mar 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 7, 2025 25.69M sh
Shares Diluted FY 2024 · Dec 31, 2024 25.35M sh
Shares Diluted FY 2024 · Dec 31, 2023 4.75M sh
Stock Repurchased FY 2024 · Dec 31, 2024 $4K
Stock Repurchased FY 2024 · Dec 31, 2023 $0
Capex FY 2024 · Dec 31, 2024 $9K
Capex FY 2024 · Dec 31, 2023 $56K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$77.26M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$28.08M
Cash And Equivalents FY 2024 · Dec 31, 2024 $30.51M
Cash And Equivalents FY 2024 · Dec 31, 2023 $140.73M
Stockholders Equity FY 2024 · Dec 31, 2024 $300.05M
Stockholders Equity FY 2024 · Dec 31, 2023 $205.04M
Stockholders Equity restated FY 2024 · Dec 31, 2022 −$19.73M
Current Liabilities FY 2024 · Dec 31, 2024 $8.91M
Current Liabilities FY 2024 · Dec 31, 2023 $5M
Total Liabilities FY 2024 · Dec 31, 2024 $8.95M
Total Liabilities FY 2024 · Dec 31, 2023 $5.25M
Current Assets FY 2024 · Dec 31, 2024 $268.84M
Current Assets FY 2024 · Dec 31, 2023 $208.87M
Total Assets FY 2024 · Dec 31, 2024 $309M
Total Assets FY 2024 · Dec 31, 2023 $210.3M
Eps Diluted FY 2024 · Dec 31, 2024 −$2.89
Eps Diluted FY 2024 · Dec 31, 2023 −$8.87
Eps Basic FY 2024 · Dec 31, 2024 −$2.89
Eps Basic FY 2024 · Dec 31, 2023 −$8.87
Sga Expense FY 2024 · Dec 31, 2024 $22.75M
Sga Expense FY 2024 · Dec 31, 2023 $13.04M
Rd Expense FY 2024 · Dec 31, 2024 $66.99M
Rd Expense FY 2024 · Dec 31, 2023 $32.37M
Net Income FY 2024 · Dec 31, 2024 −$73.21M
Net Income FY 2024 · Dec 31, 2023 −$42.12M
Operating Income FY 2024 · Dec 31, 2024 −$89.73M
Operating Income FY 2024 · Dec 31, 2023 −$45.41M